JP2011507840A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507840A5 JP2011507840A5 JP2010539387A JP2010539387A JP2011507840A5 JP 2011507840 A5 JP2011507840 A5 JP 2011507840A5 JP 2010539387 A JP2010539387 A JP 2010539387A JP 2010539387 A JP2010539387 A JP 2010539387A JP 2011507840 A5 JP2011507840 A5 JP 2011507840A5
- Authority
- JP
- Japan
- Prior art keywords
- drug delivery
- delivery system
- pharmaceutically active
- active substance
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SE2007/001128 WO2009078755A1 (en) | 2007-12-19 | 2007-12-19 | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| SEPCT/SE2007/001128 | 2007-12-19 | ||
| PCT/SE2008/051517 WO2009078804A1 (en) | 2007-12-19 | 2008-12-18 | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011507840A JP2011507840A (ja) | 2011-03-10 |
| JP2011507840A5 true JP2011507840A5 (OSRAM) | 2012-01-05 |
| JP5466174B2 JP5466174B2 (ja) | 2014-04-09 |
Family
ID=40795733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539387A Expired - Fee Related JP5466174B2 (ja) | 2007-12-19 | 2008-12-18 | 水溶性、カチオン性および両親媒性の薬学的に活性な物質を投与するためのドラッグ・デリバリー・システム |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8324274B2 (OSRAM) |
| EP (1) | EP2231193B1 (OSRAM) |
| JP (1) | JP5466174B2 (OSRAM) |
| KR (1) | KR101616135B1 (OSRAM) |
| CN (1) | CN101945671B (OSRAM) |
| AU (1) | AU2008339101B2 (OSRAM) |
| BR (1) | BRPI0821739B8 (OSRAM) |
| CA (1) | CA2709268C (OSRAM) |
| CY (1) | CY1121145T1 (OSRAM) |
| DK (1) | DK2231193T3 (OSRAM) |
| EA (1) | EA018559B1 (OSRAM) |
| ES (1) | ES2689509T3 (OSRAM) |
| HR (1) | HRP20181517T1 (OSRAM) |
| HU (1) | HUE039695T2 (OSRAM) |
| LT (1) | LT2231193T (OSRAM) |
| MX (1) | MX2010006906A (OSRAM) |
| MY (1) | MY150820A (OSRAM) |
| NZ (1) | NZ586858A (OSRAM) |
| PL (1) | PL2231193T3 (OSRAM) |
| PT (1) | PT2231193T (OSRAM) |
| SI (1) | SI2231193T1 (OSRAM) |
| WO (2) | WO2009078755A1 (OSRAM) |
| ZA (1) | ZA201004992B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009078756A1 (en) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| WO2009078754A1 (en) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| CN112239418B (zh) * | 2019-07-18 | 2023-07-07 | 上海现代药物制剂工程研究中心有限公司 | 视黄醇类化合物及其钠盐的制备方法 |
| CN112321465B (zh) * | 2019-07-18 | 2023-06-06 | 上海现代药物制剂工程研究中心有限公司 | 一种含苯基化合物、其中间体、制备方法及应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197809B1 (en) * | 1998-12-23 | 2001-03-06 | Ardenia Investments Ltd. | Compounds for the treatment of cancer |
| JP4643009B2 (ja) * | 1999-03-11 | 2011-03-02 | アーデニア・インベストメンツ・リミテッド | 癌治療のための新規化合物 |
| US6656504B1 (en) | 1999-09-09 | 2003-12-02 | Elan Pharma International Ltd. | Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| SE0101702D0 (sv) * | 2001-05-15 | 2001-05-15 | Ardenia Investments Ltd | Novel potentiating compounds |
| KR100566911B1 (ko) * | 2001-06-25 | 2006-04-03 | 주식회사 삼양사 | 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체 |
| US20050191359A1 (en) * | 2001-09-28 | 2005-09-01 | Solubest Ltd. | Water soluble nanoparticles and method for their production |
| US20050249786A1 (en) * | 2001-09-28 | 2005-11-10 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| JP2004010479A (ja) * | 2002-06-03 | 2004-01-15 | Japan Science & Technology Corp | ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法 |
| SE0202311D0 (sv) * | 2002-07-23 | 2002-07-23 | Ardenia Investments Ltd | Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment |
| JP2006199590A (ja) * | 2003-09-04 | 2006-08-03 | Nano Career Kk | 水溶性の塩基性薬物内包ナノ粒子含有組成物 |
| US20050196343A1 (en) * | 2004-02-27 | 2005-09-08 | Molecular Therapeutics, Inc. | Degradable nanoparticles |
| US8945629B2 (en) * | 2004-09-10 | 2015-02-03 | University Of Wyoming | Nanoparticles for cytoplasmic drug delivery to cancer cells |
| CA2598239C (en) * | 2005-02-18 | 2019-10-29 | Abraxis Bioscience, Inc. | Nanoparticulate formulations of taxanes and carrier proteins for use in combination chemotherapy |
| AU2006284657B2 (en) * | 2005-08-31 | 2012-07-19 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| WO2009078754A1 (en) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| WO2009078756A1 (en) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
-
2007
- 2007-12-19 WO PCT/SE2007/001128 patent/WO2009078755A1/en not_active Ceased
-
2008
- 2008-12-18 HU HUE08863195A patent/HUE039695T2/hu unknown
- 2008-12-18 HR HRP20181517TT patent/HRP20181517T1/hr unknown
- 2008-12-18 KR KR1020107015634A patent/KR101616135B1/ko active Active
- 2008-12-18 JP JP2010539387A patent/JP5466174B2/ja not_active Expired - Fee Related
- 2008-12-18 ES ES08863195.7T patent/ES2689509T3/es active Active
- 2008-12-18 EA EA201070626A patent/EA018559B1/ru unknown
- 2008-12-18 CA CA2709268A patent/CA2709268C/en active Active
- 2008-12-18 MY MYPI20102785 patent/MY150820A/en unknown
- 2008-12-18 NZ NZ586858A patent/NZ586858A/en not_active IP Right Cessation
- 2008-12-18 PL PL08863195T patent/PL2231193T3/pl unknown
- 2008-12-18 MX MX2010006906A patent/MX2010006906A/es active IP Right Grant
- 2008-12-18 AU AU2008339101A patent/AU2008339101B2/en not_active Ceased
- 2008-12-18 EP EP08863195.7A patent/EP2231193B1/en active Active
- 2008-12-18 WO PCT/SE2008/051517 patent/WO2009078804A1/en not_active Ceased
- 2008-12-18 DK DK08863195.7T patent/DK2231193T3/en active
- 2008-12-18 US US12/809,265 patent/US8324274B2/en active Active
- 2008-12-18 CN CN2008801270941A patent/CN101945671B/zh not_active Expired - Fee Related
- 2008-12-18 BR BRPI0821739A patent/BRPI0821739B8/pt not_active IP Right Cessation
- 2008-12-18 SI SI200831998T patent/SI2231193T1/sl unknown
- 2008-12-18 LT LTEP08863195.7T patent/LT2231193T/lt unknown
- 2008-12-18 PT PT08863195T patent/PT2231193T/pt unknown
-
2010
- 2010-07-14 ZA ZA2010/04992A patent/ZA201004992B/en unknown
-
2018
- 2018-10-03 CY CY20181101023T patent/CY1121145T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507838A5 (OSRAM) | ||
| Khuroo et al. | Topotecan–tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential | |
| US11471422B2 (en) | Stealth, targeted nanoparticles (STN) for oral drug delivery | |
| Bharali et al. | Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise | |
| US9662401B2 (en) | Targeting-enhanced anticancer nanoparticles and preparation methods of same | |
| SI2231189T1 (en) | A delivery system for administering pharmaceutical active substances that are poorly soluble in water | |
| JP2018530606A5 (OSRAM) | ||
| US20190015335A1 (en) | Hepatoprotective particles and systems and methods of use thereof | |
| JP2011506276A5 (OSRAM) | ||
| He et al. | Preparation and in vitro–in vivo evaluation of teniposide nanosuspensions | |
| JP2011507840A5 (OSRAM) | ||
| JP2011507839A5 (OSRAM) | ||
| Mete et al. | Sorafenib loaded ZIF-8 metal-organic frameworks as a multifunctional nano-carrier offers effective hepatocellular carcinoma therapy | |
| JP2006500387A (ja) | 固形ナノ医薬およびその調製方法 | |
| CN103110594A (zh) | 一种阿托伐他汀钙纳米冻干粉及其制备方法 | |
| JP5466174B2 (ja) | 水溶性、カチオン性および両親媒性の薬学的に活性な物質を投与するためのドラッグ・デリバリー・システム | |
| Huang et al. | Lipid-assisted PEG-b-PLA nanoparticles with ultrahigh SN38 loading capability for efficient cancer therapy | |
| CN105853378A (zh) | 白藜芦醇烟酸酯纳米结晶速释胶囊制剂及其制备工艺 | |
| CN106031726A (zh) | 多西紫杉醇、小檗胺双载药壳聚糖纳米粒及其制备方法 | |
| Devara et al. | Preparation, optimization and evaluation of intravenous curcumin nanosuspensions intended to treat liver fibrosis | |
| CN103239401B (zh) | 一种非诺贝特纳米混悬剂及其制备方法 | |
| KR20160122310A (ko) | 독소루비신 및 이리노테칸을 포함하는 항암용 약학 조성물 및 이의 제조방법 | |
| KR20090117331A (ko) | 폐-표적지향을 위한 약학 조성물 | |
| CN104971351A (zh) | 药物组合物及其应用 | |
| Singh et al. | Therapeutic potential of nano assisted delivery in tuberculosis and its management |